Buy

Coromandel International (CRIN) continued to deliver healthy operating performance in 2QFY26 (EBIT up 15% YoY), supported by continued traction in crop protection (EBIT up 34% YoY) and nutrients and allied (EBIT up 16% YoY).

Q1FY2026 Consolidated revenue of Rs. 7,042 crore was up 49% y-o-y. Revenues increased due to strong volume growth in the fertilizer and the crop protection business and increase in subsidy.

Q4FY2025 Consolidated revenue of Rs. 4,988 crore (up 27.5%y-o-y) was ahead of our estimates. Revenues increased due to strong volume growth in the fertilizer and the crop protection business.

Coromandel International (CRIN) reported a robust operating performance in 4QFY25 (EBIT up 62% YoY), aided by strong growth in both the Crop Protection business (EBIT up 60% YoY) and the Nutrients and Allied business (Adj. EBIT up 38% YoY; includes INR509.4m toward an adjustment for the write-down of
certain assets across plants).

Coromandel International announced the signing of definitive agreements to acquire a majority stake in NACL Industries Limited (NACL). Coromandel is set to acquire 53% shareholding in NACL industries, for consideration of Rs 820 Crores at Rs 76.7/- price per share from the current promoter KLR Products Limited.

Coromandel International (CRIN) reported subdued operating performance in 2QFY25 (EBIT down 10% YoY) due to a lower NBS rate and high raw material prices.

Revenues reached Rs. 7,433 crore, rising by 6% y-o-y and by 57% q-o-q, primarily driven by higher volumes of primary sales.